机构:[1]Shenzhen Eye Hospital, Jinan University, People’s Republic of China[2]Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, People’s Republic of China南方医科大学深圳医院深圳医学信息中心[3]School of Management and E-Business, Zhejiang Gongshang University, Hangzhou, People’s Republic of China[4]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, People’s Republic of China[5]Beijing Tongren Eye Center, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology and Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Capital Medical University, Beijing, People’s Republic of China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[6]Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China[7]Jinan University, Guangzhou, People’s Republic of China
Accurate assessment and surveillance of retinoblastoma (RB) require more efficient and objective measurements. This study aims to develop an artificial intelligence (AI) system, named RB-Care, for automatic classification and quantitative assessment of RB.A total of 3730 wide-field fundus images were included for the development and validation of 2 models in RB-Care. The first model was trained to automatically classify the images into "normal," "unseeded RB," and "seeded RB." The second model performed quantitative assessment on unseeded RB by detecting and segmenting tumors and optic discs.The classification model of RB-Care can accurately classify fundus images into 3 categories with an accuracy of 0.9734 and an area under the curve (AUC) of 0.9970. The segmentation model can make precise boundary detection and quantitative measurement on tumors and optic discs, achieving mean Intersection over Union (mIoU) of 0.9670 and Dice similarity coefficient (DSC) of 0.9780 for tumor segmentation, and mIoU of 0.9999 and DSC of 0.9999 for optic disc segmentation, which reaches a comparable level with ophthalmologists.The RB-Care achieved excellent performance in both RB classification and segmentation. Consequently, the tumor size and the distance between tumor and optic disc can be quantified, which provides an objective measurement tool for quantitative assessment and surveillance of RB in clinical settings.Developing a clinically relevant technologies for objective quantitative assessment of RB.
基金:
the National Key Research and Development Program of China (2022YFC2705002),the Shenzhen Medical Research Fund (C2301005
and A2403020), the National Natural Science Foundation of China (82271103, 82301269,82301226, and 82401315), the Sanming Project
of Medicine in Shenzhen (SZSM202311018), the Guangdong Basic and Applied Basic Research Foundation (2022A1515110865), the Shenzhen Key Medical Discipline Construction Fund (SZXK038),the Shenzhen Fund for Guangdong Provincial High level Clinical Key Specialties (SZGSP014),the Shenzhen Science and Technology R&D Fund Program (JCYJ20220530153607015 and JCYJ20240813152703005), and the China Ophthalmology New Technology Incubation Project.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|2 区医学
小类|2 区眼科学
最新[2025]版:
大类|2 区医学
小类|2 区眼科学
第一作者:
第一作者机构:[1]Shenzhen Eye Hospital, Jinan University, People’s Republic of China
共同第一作者:
通讯作者:
通讯机构:[2]Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, People’s Republic of China[7]Jinan University, Guangzhou, People’s Republic of China
推荐引用方式(GB/T 7714):
Hu Yarou,Zhao Xinyu,Wu Zhenquan,et al.RB-Care: An Artificial Intelligence System for Automatic Quantitative Assessment and Surveillance of Retinoblastoma[J].Translational Vision Science & Technology.2025,14(8):15.doi:10.1167/tvst.14.8.15.
APA:
Hu Yarou,Zhao Xinyu,Wu Zhenquan,Yang Xudong,Xie Liqiong...&Zhang Guoming.(2025).RB-Care: An Artificial Intelligence System for Automatic Quantitative Assessment and Surveillance of Retinoblastoma.Translational Vision Science & Technology,14,(8)
MLA:
Hu Yarou,et al."RB-Care: An Artificial Intelligence System for Automatic Quantitative Assessment and Surveillance of Retinoblastoma".Translational Vision Science & Technology 14..8(2025):15